King of Prussia, PA, United States of America

Andrew J Turner

USPTO Granted Patents = 15 


Average Co-Inventor Count = 3.8

ph-index = 9

Forward Citations = 512(Granted Patents)


Location History:

  • Eagleville, PA (US) (2009)
  • Durham, NC (US) (2014 - 2017)
  • King of Prussia, PA (US) (2006 - 2018)

Company Filing History:


Years Active: 2006-2018

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: Andrew J Turner: Innovator in Biopharmaceuticals

Introduction

Andrew J Turner is a prominent inventor based in King of Prussia, Pennsylvania, recognized for his significant contributions to the field of biopharmaceuticals. With a notable portfolio of 15 patents, Turner has established himself as a leading figure in the development of innovative therapeutic agents.

Latest Patents

Turner's latest inventions include groundbreaking advancements in the area of albumin fusion proteins. His patent encompasses these proteins, along with nucleic acid molecules encoding them. The invention extends to vectors that contain these nucleic acids, host cells transformed with them, and methods for producing and utilizing these proteins. Importantly, the pharmaceutical compositions created using albumin fusion proteins aim at treating, preventing, or ameliorating various diseases and conditions.

Another significant patent focuses on modified vasoactive intestinal peptides (VIPs). This innovation includes encoding polynucleotides and vectors, as well as pharmaceutical compositions featuring modified VIP agents. These modified peptides boast an extended circulatory half-life and enhanced receptor-binding capabilities, improving their potency and efficacy in therapeutic applications.

Career Highlights

Throughout his career, Andrew J Turner has contributed to esteemed organizations such as Human Genome Sciences, Inc. and Delta Biotechnology Limited. His work in these companies has played a crucial role in the advancement of biopharmaceutical technologies and has influenced a wide range of medical applications.

Collaborations

Turner has collaborated with notable professionals in his field, including David James Ballance and Christopher P Prior. These partnerships have facilitated research and development, leading to innovative solutions that meet the needs of modern medicine.

Conclusion

In conclusion, Andrew J Turner exemplifies the spirit of innovation in the biopharmaceutical sector. His extensive patent portfolio and collaborative efforts underscore his commitment to improving healthcare through novel therapeutic strategies. As he continues to push the boundaries of science, the impact of his inventions is likely to be felt for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…